Current Headlines
-
Genseq Selects Sapio LIMS To Power Best-In-Class Next-Generation Sequencing Services
3/18/2024
Genseq, a Dublin-based, CAP-accredited laboratory providing a range of services for biopharma and clinical research, has adopted the science-aware lab informatics platform from Sapio Sciences to manage its next-generation sequencing (NGS) and biobanking workflows.
-
Labcorp Presents New Research Demonstrating Clinical Impact Of Precision Diagnostics In Guiding Biomarker-Targeted Therapies For Patients With Epithelial Ovarian Cancer
3/16/2024
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today presented the results from two studies at the 2024 SGO Annual Meeting on Women's Cancer.
-
Revvity Introduces New Workflow To Accelerate Newborn Sequencing Research
3/15/2024
Revvity, Inc. today announced the introduction of a flexible end-to-end workflow solution for newborn research, enabling users to utilize different instruments, reagents and databases based on a lab’s needs.
-
Auburn Community Hospital (ACH) Is The First In The U.S. To Implement Abbott's Newest & Most Advanced Laboratory Technology
3/14/2024
Auburn Community Hospital (ACH) is the first institution in the United States to integrate Abbott's Alinity h‐series into the ACH Core Laboratory. This cutting-edge hematology automation system is set to transform the capabilities of the Auburn Laboratory.
-
New Tuberculosis Test Could Improve TB Care Globally By Increasing Access To Testing In Low- And Middle-Income Countries
3/14/2024
A new tuberculosis (TB) test disclosed in the Association for Diagnostics & Laboratory Medicine's (formerly AACC's) Clinical Chemistry journal would allow testing for TB treatment monitoring to occur outside of a biosafety level 3 (BSL-3) laboratory.
-
Fabric Genomics Partners With Intermountain Children’s Health To Enhance Precision Diagnosis Of Infants And Children Using Whole Genome Sequencing From Broad Clinical Labs
3/13/2024
Fabric Genomics, the leader in artificial intelligence (AI)-powered next generation sequencing interpretation, is announcing a new partnership with Intermountain Children’s Health to analyze the whole genomes of children sequenced by the Broad Clinical Labs to help speed diagnosis of kids who may have genetic diseases.
-
Physicians Lab Launches The First-Of-Its-Kind At-Home Lab Test For Myostatin And Follistatin Levels
3/13/2024
Physicians Lab, a provider of at-home lab testing for integrative medicine and wellness, launched a new at-home lab test that measures the analytes myostatin and follistatin.
-
Beckman Coulter And Fujirebio Expand Partnership To Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics
3/12/2024
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
-
Optimal’s SciYbotic Range Of Quality Assurance Equipment Represents A Paradigm Shift In Tablet Testing
3/12/2024
Revolutionising the quality control of tablets, the Optimal Group has developed the SciYbotic range of oral solid dose (OSD) Quality Test Machines for high-speed, at-line operations.
-
Capital Digestive Care Launches AI-Driven LGI-Flag Algorithm For Predicting Lower Gastrointestinal Disorders Including Colorectal Cancer In The United States
3/12/2024
Capital Digestive Care, the largest private gastroenterology (GI) practice in the Mid-Atlantic region, today announced that it is launching LGI-Flag in the United States.